Fingerprint
Dive into the research topics of 'Phase i trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies
Nishitha Reddy, Peter M. Voorhees, Brett E. Houk, Nicoletta Brega, James M. Hinson, Anand Jillela
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations